Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study, Breast Cancer Research and Treatment, April 2012, Springer Science + Business Media,
DOI: 10.1007/s10549-012-2045-1.
You can read the full text:
Contributors
The following have contributed to this page
